BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7681258)

  • 1. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.
    Van Leer EH; Ronco P; Verroust P; van der Wal AM; Hoedemaeker PJ; De Heer E
    Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage.
    van Leer EH; de Roo GM; Bruijn JA; Hoedemaeker PJ; de Heer E
    Exp Nephrol; 1993; 1(5):292-300. PubMed ID: 7915960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a 330-kDa glycoprotein from human kidney similar to the Heymann nephritis autoantigen (gp330).
    Kanalas JJ; Makker SP
    J Am Soc Nephrol; 1990 Nov; 1(5):792-8. PubMed ID: 2133428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis.
    Makker SP
    J Immunol; 1993 Dec; 151(11):6500-8. PubMed ID: 8245481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
    Natori Y; Hayakawa I; Shibata S
    Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of receptor-associated 39/45 kD protein in active Heymann nephritis.
    Huang J; Makker SP
    Kidney Int; 1995 Feb; 47(2):432-41. PubMed ID: 7723231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Heymann nephritis with a gp330/megalin fusion protein.
    Raychowdhury R; Zheng G; Brown D; McCluskey RT
    Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.
    Tsukada Y; Ono K; Maezawa A; Yano S; Naruse T
    Clin Exp Immunol; 1994 May; 96(2):303-10. PubMed ID: 8187338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity and cross-reactive idiotypes of anti-gp330 autoantibodies in active Heymann nephritis.
    Specht Grijp-Glandorf RJ; De Heer E; Dekker-Nooren CC; Daha MR; Van Es LA
    Immunology; 1990 Jul; 70(3):290-5. PubMed ID: 1696240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein.
    Orlando RA; Kerjaschki D; Farquhar MG
    J Am Soc Nephrol; 1995 Jul; 6(1):61-7. PubMed ID: 7579071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel autoantibody to plasminogen and its characterization in Heymann nephritis.
    Makker SP
    Clin Immunol Immunopathol; 1994 Jul; 72(1):105-13. PubMed ID: 8020183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
    Kerjaschki D; Farquhar MG
    J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of two forms of GP330. Their role in Heymann nephritis.
    Bachinsky DR; Zheng G; Niles JL; McLaughlin M; Abbate M; Andres G; Brown D; McCluskey RT
    Am J Pathol; 1993 Aug; 143(2):598-611. PubMed ID: 8342605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerulopathy induced by a single monoclonal autoantibody against GP330.
    Luca ME; Deelder AM; Hogendoorn PC; Daha MR; Galceran M; van Es LA; de Heer E
    Nephrol Dial Transplant; 1995; 10(4):490-6. PubMed ID: 7623990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the nephritogenic autoantibody of Heymann's nephritis on plasminogen-binding to gp330 and activation by urokinase.
    Kanalas JJ
    Biochim Biophys Acta; 1993 Nov; 1225(1):101-6. PubMed ID: 8241286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dipeptidyl peptidase IV (gp 108) in passive Heymann nephritis. Use of dipeptidyl peptidase IV-deficient rats.
    Natorio Y; Hayakawa I; Shibata S
    Am J Pathol; 1989 Feb; 134(2):405-10. PubMed ID: 2563637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephritogenic and non-nephritogenic epithelial antigens in autoimmune and passive Heymann nephritis.
    Miettinen A; Törnroth T; Ekblom P; Virtanen I; Linder E
    Lab Invest; 1984 Apr; 50(4):435-46. PubMed ID: 6708453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease.
    Oleinikov AV; Feliz BJ; Makker SP
    J Am Soc Nephrol; 2000 Jan; 11(1):57-64. PubMed ID: 10616840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.